1. Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
   Lana Kupershmidt et al, 2012, Mechanisms of Ageing and Development CrossRef
2. Development of Dual Inhibitors against Alzheimer’s Disease Using Fragment-Based QSAR and Molecular Docking
   Manisha Goyal et al, 2014, BioMed Research International CrossRef
3. QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease
   Ignacio Ponzoni et al, 2019, Scientific Reports CrossRef
4. Biological Diagnosis of Alzheimer’s Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?
   Benoît Souchet et al, 2023, International Journal of Molecular Sciences CrossRef
5. Metallostasis and amyloid β-degrading enzymes
   Giuseppe Grasso et al, 2012, Metallomics CrossRef
6. The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
   Lana Kupershmidt et al, 2023, Cells CrossRef
7. Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease
   Megan K. Gautier et al, 2024, Neurobiology of Aging CrossRef
8. Implications of alpha- and beta-secretase expression and function in Alzheimer's disease
   Sven Reinhardt et al, 2020, Genetics, Neurology, Behavior, and Diet in Dementia CrossRef
9. Age-dependent changes in the protein expression levels of Redd1 and mTOR in the gerbil hippocampus during normal aging
   HEE-SOO CHOI et al, 2016, Molecular Medicine Reports CrossRef